EARNINGS
McKesson talks about AI as one piece of a bigger automation effort
McKesson wrapped up the Q3 earnings season with a call on Nov. 4 where its leadership talked about how several years of technology investment are paying off. They put a few things together: the physical systems in its distribution centers, software that automates routine business processes (known as robotic process automation), and large language models, the technology behind generative AI tools. The company said these investments are helping it run its distribution business better and serve its customers better.
What's interesting is how McKesson framed it. It didn't present AI as a separate, standalone initiative, and Distribution Strategy Group points out that the company didn't put a number on how much AI contributes financially. McKesson also added 67 programs covering 58 pharmaceutical brands this quarter, which help patients get their prescribed medications and work through coverage requirements, and it introduced automated medical prior authorization, the insurance approval step that some treatments require. It didn't describe either of those as AI, though. For an industry with plenty of AI announcements, it's a more measured way to talk about it.
67
programs McKesson added this quarter, covering 58 pharmaceutical brands — not described as AI applications
